Les lymphomes anaplasiques à grandes cellules associés aux prothèses mammaires : du diagnostic au séquençage moléculaire Article à paraître

  • [1] Keech J.A. Jr., Creech B.J. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554-555. 2
  • [2] Swerdlow S., Campo E., Harris N.L., Jaffe E.S. World health organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. 4 editionth
  • [3] Laurent C., Baron M., Amara N. Impact of expert pathologic review of lymphoma diagnosis: study of patients from the french lymphopath network. J Clin Oncol. 2017;35:2008-2017. 18
  • [4] Laurent C., Delas A., Gaulard P. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27:306-314. 2
  • [5] Laurent C., Haioun C., Brousset P., Gaulard P. New insights into breast implant-associated anaplastic large cell lymphoma. Curr Opin Oncol. 2018;30:292-300. 5
  • [6] Srinivasa D.R., Miranda R.N., Kaura A. Global adverse event reports of breast implant-associated alcl: an international review of 40 government authority databases. Plast Reconstr Surg. 2017;139:1029-1039. 5
  • [7] Brody G.S., Deapen D., Taylor C.R. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135:695-705. 3
  • [8] Leberfinger A.N., Behar B.J., Williams N.C. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017;152:1161-1168. 12
  • [9] de Boer M., van Leeuwen F.E., Hauptmann M. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol. 2018;4:335-341. 3
  • [10] Doren E.L., Miranda R.N., Selber J.C. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042-1050. 5
  • [11] de Jong D., Vasmel W.L., de Boer J.P. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300:2030-2035. 17
  • [12] Jaffe E.S., Ashar B.S., Clemens M.W. Best practices guideline for the pathologic diagnosis of breast implant–associated anaplastic large-cell lymphoma. J Clin Oncol. 2020;38:1102-1111. 10
  • [13] Le Bras F, Bosc R, Laurent C, et al. Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL): the lymphoma study association (LYSA) registry data. ASCO 2019, abstract number 129123.
  • [14] Miranda R.N., Aladily T.N., Prince H.M. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114-120. 2
  • [15] Laurent C., Nicolae A., Le Bras F. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood. 2020;135:360-370. 5
  • [16] Oishi N, Hundal T, Phillips JL, et al. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma. Haematologica 2020 May 15:haematol.2019.245860. doi: 10.3324/haematol.2019.245860. Epub ahead of print. PMID: 32414854.
  • [17] Di Napoli A., De Cecco L., Piccaluga P.P. Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas. Mod Pathol. 2019;32:216-230. 2
  • [18] Crescenzo R., Abate F., Lasorsa E. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015;27:516-532. 4
  • [19] Clemens M.W., Medeiros L.J., Butler C.E. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160-168. 2
  • [20] Hu H., Johani K., Almatroudi A. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659-1669. 6
  • [21] Adams W.P. Jr., Culbertson E.J., Deva A.K. Macrotextured breast implants with defined steps to minimize bacterial contamination around the device : experience in 42,000 implants. Plast Reconstr Surg. 2017;140:427-431. 3
  • [22] Kadin M.E., Deva A., Xu H. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016;36:773-781. 7